Bipyridine tricarbonyl technetium-99m-marked long-chain fatty acid derivative and application thereof
A technology of long-chain fatty acids and bispyridines, which is applied in the field of long-chain fatty acid derivatives labeled with new bispyridine tricarbonyl technetium-99m, which can solve the problems of slow metabolism and affecting imaging effects, and improve the labeling rate and reduce the Liver background, providing feasibility and operability effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0051] The general structural formula of the novel bispyridine tricarbonyl technetium-99m labeled long-chain fatty acid derivative is:
[0052]
[0053] where A is -CH 2 or E is -CH 2 or no a , n b are positive integers, n a 1-16, n b is 0 or 1, and when n b When it is 1, R is S, O or N.
[0054] As a further preferred embodiment, n b is 0, A is -CH 2 , E is -CH 2 or , the structure of the long-chain fatty acid derivative labeled with bispyridine tricarbonyl technetium-99m is: Among them, n a It is a positive integer of 4-12;
[0055] As a further preferred embodiment, the structure of the long-chain fatty acid derivative labeled with bispyridine tricarbonyl technetium-99m is: Among them, n a It is a positive integer of 4-12;
[0056] As a further preferred embodiment, n b When it is 1, R is S, O or N, and A is -CH 2 or E is -CH 2 or no a It is a positive integer of 1-16.
[0057] As a further preferred embodiment, n b When it is 1, R is S,...
Embodiment 2
[0062] Embodiment 2: the synthetic route of following compound is:
[0063] 1, where n 1 is 8-16, R is S, O or N;
[0064]
[0065] 2, where n 2 is 8-14, R is S, O or N;
[0066]
[0067] 3. where n 2 is 8-14, R is S, O or N;
[0068]
[0069] 4. where n 2 is 8-14, R is S, O or N;
[0070]
Embodiment 3
[0072] Embodiment 3: Preparation of marker intermediate
[0073] fac-[ 99m Tc(CO) 3 (H 2 O) 3 ] + Preparation of intermediates: Take 5mgNa2CO3, 10mgNaBH4, 15mg sodium potassium tartrate in a 10mL penicillin vial, add 1ml of normal saline to it, shake well, use a 10ml disposable needle to evacuate, pass the gas in the carbon monoxide for 15min, and drain the bottle air, then inject 2mlNa 99m TCO4 The eluate (about 13mci) was continuously heated in an 80°C oil bath for 30min (carbon monoxide gas was passed through during the reaction), cooled to obtain the intermediate [ 99m Tc(CO) 3 (H 2 O) 3 ] + , to be used, the intermediate intermediate [ 99m Tc(CO) 3 (H 2 O) 3 ] + The HPLC diagram is as follows Figure 8 shown.
[0074] Synthetic intermediates of rhenium complexes [NEt 4 ] 2 [Re(CO) 3 Br 3 ] preparation: under nitrogen protection, weigh 505.4mg (1.2mmol) tetraethylamine bromide and 415.2mg (1.0mmol) pentacarbonyl rhenium bromide, add diethylene glycol di...
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com